Avidity Biosciences Inc. (RNA) Social Stream
AVIDITY BIOSCIENCES INC (RNA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RNA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 4 | $50 | $36 | $45.333 | $11.25 | 302.96% |
| 2021-12-10 | 4 | $53 | $50 | $51 | $11.25 | 353.33% |
| 2022-05-10 | 4 | $50 | $50 | $50 | $11.25 | 344.44% |
| 2022-08-10 | 5 | $50 | $29 | $39.5 | $11.25 | 251.11% |
| 2022-09-28 | 5 | $50 | $27.001 | $35.25 | $11.25 | 213.33% |
| 2022-11-09 | 5 | $50 | $27 | $35.5 | $11.25 | 215.56% |
| 2022-12-14 | 5 | $71 | $27 | $45.75 | $11.25 | 306.67% |
| 2023-03-01 | 6 | $71 | $27 | $47.6 | $11.25 | 323.11% |
| 2023-03-30 | 6 | $71 | $27 | $44.8 | $11.25 | 298.22% |
| 2023-04-28 | 6 | $71 | $26 | $42.8 | $11.25 | 280.44% |
| 2023-05-10 | 7 | $71 | $26 | $42.8 | $11.25 | 280.44% |
| 2023-05-11 | 7 | $71 | $20 | $39 | $11.25 | 246.67% |
| 2023-08-08 | 7 | $71 | $20 | $39 | $11.25 | 246.67% |
| 2023-08-10 | 7 | $71 | $20 | $37.833 | $11.25 | 236.29% |
| 2023-11-09 | 6 | $71 | $23 | $41.4 | $11.25 | 268% |
| 2023-11-28 | 6 | $71 | $18 | $40.4 | $11.25 | 259.11% |
The Trend in the Analyst Price Target
RNA's average price target has moved down $10.6 over the prior 24 months.
Over the past 39 weeks, RNA's average upside potential has been 345.75%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-08-10 | 6 | 71 | 23 | 41.400 | 8.96 | 362.05% |
| 2023-08-10 | 6 | 71 | 20 | 37.833 | 8.96 | 322.24% |
| 2023-08-10 | 7 | 71 | 23 | 41.400 | 8.96 | 362.05% |
| 2023-11-09 | 6 | 71 | 23 | 41.400 | 5.48 | 655.47% |
| 2023-11-28 | 6 | 71 | 18 | 40.400 | 7.08 | 470.62% |
RNA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.17 | 5 | 1 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
RNA's average broker recommendation rating improved by 0.58 over the prior 29 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, AVIDITY BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 1793.83% of them.
- In terms of how AVIDITY BIOSCIENCES INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1260.9% of that group.
- AVIDITY BIOSCIENCES INC's number of analysts covering the stock is higher than 451.48% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, AVIDITY BIOSCIENCES INC's average analyst price target is higher than 1712.28% of them.
Stocks similar to AVIDITY BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are GBIO, RPTX, and IVA.
View All Top Stocks by Price Target
Make investment decisions regarding RNA using the data that counts. Try POWR Ratings for free.